BEIJING (Reuters) – The first batch of BioNTech SE’s COVID-19 vaccine is expected to arrive in Taiwan on Thursday, a total of 932,000 shots, China’s official Xinhua news agency reported on Wednesday.
Xinhua, in a brief report, said the vaccines were being provided by Shanghai Fosun Pharamceutical, which has the right to sell the shots on BioNTech’s behalf in China, Hong Kong, Macau and Taiwan.
(Reporting by Beijing newsroom; Writing by Ben Blanchard; Editing by Tom Hogue)
